1. Home
  2. HNNA vs VNRX Comparison

HNNA vs VNRX Comparison

Compare HNNA & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

HOLD

Current Price

$10.32

Market Cap

76.4M

Sector

Finance

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.30

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNNA
VNRX
Founded
1989
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
38.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HNNA
VNRX
Price
$10.32
$0.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.17
AVG Volume (30 Days)
8.9K
2.6M
Earning Date
12-03-2025
11-13-2025
Dividend Yield
5.50%
N/A
EPS Growth
38.04
N/A
EPS
1.27
N/A
Revenue
$35,538,000.00
$1,472,007.00
Revenue This Year
N/A
$55.33
Revenue Next Year
N/A
$493.79
P/E Ratio
$7.87
N/A
Revenue Growth
19.88
14.48
52 Week Low
$8.43
$0.27
52 Week High
$13.88
$0.94

Technical Indicators

Market Signals
Indicator
HNNA
VNRX
Relative Strength Index (RSI) 46.88 35.58
Support Level $9.33 $0.27
Resistance Level $10.39 $0.33
Average True Range (ATR) 0.32 0.03
MACD 0.02 0.00
Stochastic Oscillator 61.47 31.95

Price Performance

Historical Comparison
HNNA
VNRX

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: